📉 Quiet M&A, Hemp Tightens, Ballot Fights Get Expensive

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition tracks the quiet reality behind the consolidation chatter: deals are still happening, but they’re showing up as lender processes, note plays, and distressed exits instead of splashy MSO mergers. We also cover hemp tightening at the state level from New Jersey to Texas, Florida’s petition probe turning into arrests, and early money pouring into 2026 ballot fights.

Today’s edition is supported by The AI Report. This briefing is also supported by our day job at THC Group, where we provide strategic counsel for policy, regulatory, and political headaches that do not come with clean rulebooks. Want to sponsor a future edition? Reach out.

🧩 Quiet deals, loud deadlines
🌾 Hemp gets boxed in
🗳️ Ballot season starts early

Deadlines decide.

📌 What Happened: Javier Hasse wrote in Forbes what a lot of people are seeing right now: deals are still getting done, just behind the scenes. Public MSO combinations remain limited because valuations are weak, cash is scarce, and sellers hesitate to accept stock as full payment. Meanwhile, consolidation is moving through private transactions, distressed asset sales, note purchases, and lender-driven restructurings that don’t need a public announcement (but still may require regulator approval!). A lot of debt comes due through 2026, and that reality is forcing operators into refinance talks or sale processes on someone else’s timetable. Bankruptcy is a limited tool here. In practice, distress gets handled through receiverships and secured-creditor remedies, and that tends to compress the timeline.

💡 Why It Matters: This round of consolidation is being driven by balance sheets and creditor terms. Viridian’s deal data and the broader transaction record point to a market where cash consideration has largely dried up, so control moves through structures that preserve cash and price risk into terms. Earnouts, rollovers, seller notes, and credit bids start taking the place of cash, and covenants get progressively tighter. Schedule III expectations and 280E relief may improve cash flow and underwriting, but they do not refill the equity market on demand, and they do not solve refinancing for businesses that are already structurally unprofitable. The practical divide is between operators who can finance and integrate in a regulatory-compliant way and operators who are running out of runway. That divide plays out differently in each state, too. Open-license markets generate more forced exits and price-setting distressed sales, while limited-license markets hold value better and attract buyers with the patience and capital to build through the cycle.

🛃 Congress Demands Answers On Federal Cannabis Seizures

Appropriators are putting Customs and Border Protection on the clock after seizures of cannabis products tied to state legal and tribal compliant businesses, a fight that has spiked in New Mexico. The directive in fiscal 2026 spending text requires CBP to brief Congress within 120 days of enactment on what is being seized, from whom, and under what authority. That oversight move signals impatience with quiet enforcement drift that can kneecap regulated supply chains even when local rules are being followed. The same package also orders a CDC public report on cannabinoid hyperemesis syndrome in youth and tightens guardrails on federal safety dollars and messaging. The near-term consequence is a real compliance exposure point for interstate shipping, border crossings, and tribal commerce until CBP clarifies its playbook in writing. (Marijuana Moment)

🎁 Federal Hemp Ban Could Hand Cannabis A Windfall

Wynk co-founder Angus Rittenburg argues that proposed federal limits on intoxicating hemp could end up functioning as a gift to state legal cannabis by forcing demand back into dispensary channels. His view is that mainstream retail access has expanded faster than oversight, and a hard federal line would shrink the gray market footprint even if it frustrates consumers in the short run. That opinion still carries a real caveat, because many hemp buyers never built a dispensary habit, so some demand may exit instead of convert. Mature cannabis markets also face a capacity and pricing question if traffic snaps back quickly. The practical consequence is a policy-driven reshuffle where the winners depend on channel readiness and compliance posture, not marketing momentum. (Yahoo Finance)

🗽 New Jersey Pulls Intoxicating Hemp Into A Tighter Box

New Jersey is closing its intoxicating hemp gap by pulling products over the limit into the cannabis framework and aligning definitions around total THC. The law captures variants and precursors that have supported gray market potency games and it pairs that with an age 21 rule. Retailers now face a short transition window that forces inventory decisions and vendor resets fast. The market consequence is channel discipline, with low dose products that can live inside clear rules getting a cleaner lane and higher potency products losing their mainstream shelf cover. New Jersey also gives neighboring states a template for closing the loophole through definition work and enforceable timing. (Mondaq)

🤠 Texas Locks In 21 Plus Hemp Rules For Bars And Stores

Texas regulators finalized permanent rules requiring age 21 sales and ID checks for consumable hemp products across roughly 60,000 TABC licensees. The agency also backed away from a one strike cancellation posture and moved toward suspensions for less egregious violations, which signals a preference for compliance correction over headline enforcement. The rules replace emergency measures adopted in September and they land in a market where enforcement authority has been fragmented. TABC is also signaling a clearer handoff framework with the health agency as the primary enforcement lead, which matters for how complaints and inspections actually flow. The immediate consequence is a compliance reset for mainstream retail and hospitality while the bigger fight shifts to health agency rules and fee structures that will decide who can afford to stay in the channel. (Texas Tribune)

🚫 South Dakota Moves To Block Intoxicating Hemp Sales To Minors

South Dakota lawmakers are moving a bill that would ban sales of intoxicating hemp cannabinoids to anyone under 21 and criminalize underage purchase, possession, and use. The measure also targets third party purchases for minors with a narrow parent or guardian exception. The policy lane is familiar, because youth access is the cleanest argument for tightening the channel without reopening broader legalization debates. The practical consequence is that behind-the-counter retail now carries a clearer enforcement hook, and the low friction gas station model becomes harder to defend. If this passes easily, it will invite copycat moves in states that want a public safety frame without a full hemp rewrite. (South Dakota Searchlight)

🌴 South Carolina Hemp Trade Group Pushes A Regulate Not Ban Path

A South Carolina hemp trade group is urging lawmakers to regulate intoxicating hemp through amendments to House Bill 3924 and is framing the push as public safety plus small business stability. The op-ed argues the state has functionally operated an open market under the federal delta-9 standard with limited guardrails, and it says that gap drives product sprawl across gummies, vapes, and beverages. The politics here are procedural, because the Senate is the real fork in the road and the question is whether the state claims jurisdiction or lets the market keep freelancing. The market consequence is that disciplined low dose models gain legitimacy when rules exist, while slapdash sellers lose the ambiguity that has protected them. This is the South’s defining hemp question in a single state fight. (Marijuana Moment)

🚔 Florida Petition Crackdown Moves From Subpoenas To Arrests

Florida officials have escalated the petition fraud investigation around the Smart and Safe Florida adult use campaign, and arrests of petition workers are now underway. The attorney general has announced dozens of new criminal investigations and issued criminal subpoenas seeking records from the committee and its vendor network. Prosecutors say circulators submitted petitions without voter consent and that forged signatures include deceased voters, and they have signaled more arrests and warrants may follow. The timing matters because the campaign is already fighting signature verification and court deadlines, so criminal process becomes part of the ballot clock. The consequence is immediate operational disruption and a credibility hit that will hang over litigation, fundraising, and vendor relationships. (MJBizDaily)

🗳️ Ohio Referendum Team Resubmits Petition To Block Senate Bill 56

Ohioans for Cannabis Choice has resubmitted revised petition summary language after the attorney general rejected the first version as misleading. The group also filed more than 1,000 voter signatures with the resubmission to restart the certification process. Senate Bill 56 is set to take effect March 20th and it reshapes parts of Ohio’s adult use framework while pushing most intoxicating hemp into dispensary channels. This resubmission keeps a November referendum threat alive and forces the state back into a process fight over what voters are being asked to sign. The consequence is extended policy uncertainty for retailers and brands as Ohio decides whether the overhaul settles in or lands on the ballot. (WOIO Cleveland19)

🗳️ Massachusetts Ballot Machine Hits $10 Million Before Campaign Season Starts

Massachusetts ballot committees have already reported nearly $10 million in spending tied to 2026 initiatives, with a large share going to signature gathering. The repeal effort targeting adult use legalization is drawing early money and early legal friction, including disputes before the State Ballot Law Commission over petition tactics. Secretary of State Bill Galvin has said a large slate of proposals has cleared the first signature hurdle, signaling a crowded and expensive cycle. The early spend is a tell because it shows which fights have institutional backing and which ones will collapse once the second signature round hits. The cannabis consequence is political whiplash risk in a mature market, with operators forced to plan for a voter fight even if the measure dies on process. (The Boston Globe)

🏷️ Pincanna Puts Its Grow And Retail Assets On The Block

Michigan operator Pincanna is selling a large cultivation facility and sending equipment to auction as it exits a market that has become structurally hard to run profitably. The company is framing the move as economics, not branding, which fits a state where competition and price compression punish even scaled operators. Auction listings show a full indoor cultivation and processing setup, and retail assets are being marketed alongside it. This is a live example of consolidation by distress, where the market resets through liquidation and asset transfers instead of clean mergers. The consequence is supply chain churn and a new distressed price floor for equipment and facilities that will shape the next buildout cycle. (Crain’s Detroit Business)

🌱 Minnesota Growers Ramp Up Plantings As Stores Stay Tight On Supply

Minnesota’s adult use cultivation ramp is finally visible, with tens of thousands of plants in the ground and growing as the legal market tries to catch up with demand. A state dashboard makes the supply buildout measurable, and it shows a late 2025 surge after the first cultivation licenses were issued in June. That lag is showing up at retail because fall plantings still need time, so shelves stay thin even while the market expands. Early sales have been strong since non-tribal dispensaries opened in September, yet median prices remain high and the public will blame retailers for a problem that starts upstream. The consequence is a near-term pricing and availability squeeze that will ease only when this pipeline turns into finished product on shelves. (Axios Twin Cities)

🍁 Canada’s Cannabis Lobbying Surge Hits Taxes, Stamps, And Illicit Trade

Canadian cannabis companies leaned hard into government relations in 2025 with excise reform, a harmonized stamp, and tougher illicit market enforcement at the center of the push. Organigram stands out for volume, reporting dozens of federal communications across a wide swath of agencies through November. Provincial activity reflects the same pressure points with distribution model debates, consumption space issues, and modernization fights that vary by province. The operating reality is that the industry has a single organizing theme, which is a cost structure that cannot breathe under current tax and compliance friction. The consequence is agenda clarity, because the firms doing the most lobbying are signaling where they think relief is politically available first. (StratCann)

💊 France’s Medical Cannabis Rollout Slips Again Despite A Finished Rulebook

France has extended its medical cannabis pilot again, keeping current patients covered beyond the March 31st cliff while the permanent program remains stuck in government limbo. The framework is largely built and technical steps have moved, yet routine prescribing still is not reaching new patients at scale. Industry voices now warn that first broad prescriptions are unlikely in 2026, which turns planning into carrying costs and forces another year of bridge solutions. This delay also creates a credibility problem for ministries that keep extending the experiment while leaving clinicians and patients without a stable national pathway. The consequence is predictable drift that punishes serious operators and rewards the status quo. (Business of Cannabis)

🥤 A THC Beverage Brand Built For The School Pickup Crowd

Anna Baskin says she founded hightail after discovering low dose THC beverages as a cleaner alternative to alcohol in social settings and a more predictable option than gummies. She ties the moment to two overlapping trends: more adults cutting back on drinking and parents reporting high daily stress, with many quietly microdosing to take the edge off. Her pitch is format control, because gummies can hit late and linger, while a drink can feel easier to time and dose. Hightail positions itself as low dose and functional, pairing 1.5 milligrams of THC with 3 milligrams of CBG and marketing that blend as calm with a little lift. The consequence is regulatory, with brands pushing wellness framing that will test age controls, minor cannabinoid claims discipline, and how close these products can sit to everyday consumer goods. (Yahoo Lifestyle)

🧪 DOJ Misses Deadline On Research Access Rules For Schedule I Drugs

The Justice Department missed a statutory deadline to finalize rules meant to streamline research on Schedule I substances, including marijuana and psychedelics. Congress ordered process changes designed to reduce duplicative review and shorten approval timelines that have slowed federally sanctioned studies for decades. The miss lands poorly as federal cannabis policy debates lean on science while the research pipeline remains clogged by process. This delay also keeps universities and clinical teams stuck in uncertainty while products are widely available through state markets. The consequence is more friction in the evidence base at the exact moment policymakers claim they want better data to guide decisions. (Marijuana Moment)